Belpointe Asset Management LLC Has $1.54 Million Stock Holdings in SPDR S&P Biotech ETF $XBI

Belpointe Asset Management LLC boosted its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 80.2% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 12,598 shares of the exchange traded fund’s stock after purchasing an additional 5,605 shares during the period. Belpointe Asset Management LLC’s holdings in SPDR S&P Biotech ETF were worth $1,536,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also bought and sold shares of XBI. JPMorgan Chase & Co. lifted its position in shares of SPDR S&P Biotech ETF by 27.3% in the third quarter. JPMorgan Chase & Co. now owns 13,538,738 shares of the exchange traded fund’s stock valued at $1,356,582,000 after buying an additional 2,900,633 shares during the last quarter. Bessemer Group Inc. boosted its stake in shares of SPDR S&P Biotech ETF by 9.3% during the 3rd quarter. Bessemer Group Inc. now owns 1,632,988 shares of the exchange traded fund’s stock worth $163,624,000 after acquiring an additional 138,322 shares during the period. Ameriprise Financial Inc. boosted its stake in shares of SPDR S&P Biotech ETF by 40.5% during the 3rd quarter. Ameriprise Financial Inc. now owns 1,226,147 shares of the exchange traded fund’s stock worth $122,906,000 after acquiring an additional 353,351 shares during the period. Meitav Investment House Ltd. boosted its stake in shares of SPDR S&P Biotech ETF by 70.3% during the 3rd quarter. Meitav Investment House Ltd. now owns 682,056 shares of the exchange traded fund’s stock worth $68,156,000 after acquiring an additional 281,602 shares during the period. Finally, Greenhouse Funds LLLP boosted its stake in shares of SPDR S&P Biotech ETF by 16.6% during the 3rd quarter. Greenhouse Funds LLLP now owns 675,975 shares of the exchange traded fund’s stock worth $67,733,000 after acquiring an additional 96,308 shares during the period.

SPDR S&P Biotech ETF Price Performance

XBI stock opened at $136.39 on Wednesday. The company has a fifty day moving average price of $126.80 and a two-hundred day moving average price of $121.49. SPDR S&P Biotech ETF has a one year low of $75.68 and a one year high of $139.19. The stock has a market cap of $9.00 billion, a price-to-earnings ratio of 11.47 and a beta of 0.88.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.